In addition, gene correlation analysis showed that the expression levels of MCM2, NUSAP1, EGFR, ERBB2, and KRAS significantly correlated, and thus, MCM2 and NUSAP1 are likely to become potential therapeutic targets for PC. This evidence concerns the gene MCM2 and pachyonychia congenita.